If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 4,372,700 shares of common stock, (ii) 50,000 shares of common stock underlying options that have vested and are exercisable as of September 22, 2026 and (iii) 251,828 shares of common stock underlying options that will vest and become exercisable within 60 days after such date, in each case held by the Reporting Person. The number of shares beneficially owned does not reflect 1,509,147 shares of common stock underlying options held by the Reporting Person that will vest more than 60 days after such date.


SCHEDULE 13D


 
Serhii Kupriienko
 
Signature:/s/ Serhii Kupriienko
Name/Title:Serhii Kupriienko
Date:09/23/2026